Nemluvio 00299-6220
Generic: Nemolizumab-Ilto
Product NDC
00299-6220- Manufacturer
- Galderma Laboratories, L.p.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 13, 2024
- Listing Expires
- December 31, 2026
- Application
- BLA761390
Need to source Nemluvio? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nemolizumab | 30 mg/100mg |
Drug Class
Interleukin-31 Receptor alpha Antagonist [EPC]Interleukin-31 Receptor alpha Antagonist [EPC]Interleukin-31 Receptor alpha Antagonists [MoA]
Packaging Options(2)
1 SYRINGE, GLASS in 1 CARTON (0299-6220-10) / 30 mg in 1 SYRINGE, GLASS
1 SYRINGE in 1 CARTON (0299-6220-15) / 30 mg in 1 SYRINGE